Foghorn Therapeutics: Jefferies cuts target price to $5 from $12
FHTX•Jefferies cut its target price for Foghorn Therapeutics to $5 from $12.
Related News
LTC Properties, Inc.: RBC raises target price to $52 from $45
LTC•
Commodities intraday targets and key levels
USO•
Alto Neuroscience President, CFO Nicholas Conrad Smith disposes of shares worth $3,547,660.32
ANRO•
Tokyo core inflation rate jumps in September, bolstering case for more BOJ hikes
EWJ•
CleanSpark CTO, COO Taylor Monnig disposes of 16,458 common shares worth $202,972
CLSK•